No Thaw In Sight: German Bill Extends Price Freeze To 2022

Drug price freeze introduced in 2010 would remain to 2022, under draft legislation to revise AMNOG reimbursement system. It introduces some limits on the year of free pricing that companies enjoy after launch.

Frozen euro

Pharma companies would continue to face frozen drug prices in Germany until 2022, according to the first draft of a new bill that reforms the AMNOG law, which regulates the country's pricing and reimbursement system.

The move makes it harder for companies to respond to changes in the market as the only way to amend...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Market Access

More from Pink Sheet